4-[4-(2-adamantylcarbamoyl)-5-tert-but yl-pyrazol-1-yl]benzoic acid - 465

Details for Australian Patent Application No. 2008326226 (hide)

Owner AstraZeneca AB

Inventors Scott, James Stewart; Stocker, Andrew; Whittamore, Paul Robert Owen; Packer, Martin

Agent Davies Collison Cave

Pub. Number AU-B-2008326226

PCT Pub. Number WO2009/060232

Priority 61/082,304 21.07.08 US; 60/985,735 06.11.07 US; PCT/ GB2008/000454 11.02.08 GB; 108/2008 04.02.08 PK

Filing date 5 November 2008

Wipo publication date 14 May 2009

Acceptance publication date 20 October 2011

International Classifications

C07D 231/14 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/415 (2006.01) - 1,2-Diazoles

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

Event Publications

20 May 2010 PCT application entered the National Phase

  PCT publication WO2009/060232 Priority application(s): WO2009/060232

20 October 2011 Application Accepted

  Published as AU-B-2008326226

16 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008326227-"Valve assembly"

2008326220-Intranasal compositions